The device, which was recently approved by the FDA, uses pulsed electric fields to efficiently and safely treat A-fib, according to a Nov. 19 press release.
The procedure was successfully performed on Sept. 9 at Northside Hospital Atlanta by cardiac electrophysiologist Alok Gambhir, MD.
Unlike traditional ablation technologies that rely on heat and risk damaging surrounding tissues, Medtronic’s non-thermal mechanism reduces the potential for collateral damage.
Atrial fibrillation currently impacts 59 million people worldwide, and can worsen overtime without early intervention.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
